• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据 mpMRI 上的指数病变特征评估除靶向活检外还需要进行系统活检的必要性。来自大型多机构数据库的结果。

Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database.

机构信息

Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Department of Radiology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

World J Urol. 2022 Nov;40(11):2683-2688. doi: 10.1007/s00345-022-04155-4. Epub 2022 Sep 23.

DOI:10.1007/s00345-022-04155-4
PMID:36149448
Abstract

PURPOSE

We hypothesized that systematic biopsies (SBx) value for clinically significant PCa (csPCa) detection, in addition to mpMRI targeted biopsies (TBx), may vary significantly according to mpMRI index lesion (IL) characteristics.

METHODS

We identified 1350 men with an mpMRI suspicious lesion (PI-RADS ≥ 3), defined as IL, who underwent TBx and SBx at three referral centres. The outcome was SBx added value in csPCa (grade group ≥ 2 PCa detected at SBx and missed by TBx) detection. To this aim, we performed multivariable logistic regression analyses (MVA). Furthermore, we explored the interaction between IL volume and SBx csPCa added value, across different PI-RADS categories, using lowess function.

RESULTS

Overall, 569 (42%) men had csPCa at TBx and 78 (6%) csPCa were identified at SBx only. At MVA PSA (OR 0.90; p < 0.05) and IL volume (OR 0.58; p < 0.05) were associated with SBx csPCa added value. At interaction analyses, a nonlinear correlation between PI-RADS and SBx csPCa added value was identified with a decrease from roughly 10 to 4% followed by a substantial plateau at 1.2 ml and 0.6 ml for PI-RADS 3 and 4, respectively. For PI-RADS 5 lesions SBx csPCa added was constantly lower than 4%.

CONCLUSIONS

Increasing IL volume in PI-RADS 3 and 4 lesions is associated with reduction in SBx csPCa added value. For diagnostic purposes, SBx could be omitted in men with IL larger than 1.2 ml and 0.6 ml for PI-RADS 3 and 4, respectively. Conversely, for PI-RADS 5, SBx csPCa added value was minimal regardless of IL volume.

摘要

目的

我们假设系统活检(SBx)在检测临床显著前列腺癌(csPCa)方面的价值,除了 mpMRI 靶向活检(TBx)外,还可能根据 mpMRI 指数病变(IL)的特征而显著不同。

方法

我们在三个转诊中心共确定了 1350 名 mpMRI 可疑病变(PI-RADS≥3)患者,将其定义为 IL,这些患者接受了 TBx 和 SBx。研究结果为 SBx 在 csPCa(在 SBx 中检测到的分级组≥2 的 PCa,而在 TBx 中漏诊)检测中的附加价值。为此,我们进行了多变量逻辑回归分析(MVA)。此外,我们使用低通函数探索了 IL 体积与 SBx csPCa 附加价值之间的相互作用,跨越了不同的 PI-RADS 类别。

结果

总体而言,569 名(42%)男性在 TBx 时患有 csPCa,78 名(6%)男性仅在 SBx 时患有 csPCa。在 MVA 中,PSA(OR 0.90;p<0.05)和 IL 体积(OR 0.58;p<0.05)与 SBx csPCa 附加价值相关。在交互分析中,发现 PI-RADS 与 SBx csPCa 附加价值之间存在非线性相关性,从大约 10%降至 4%,然后在 PI-RADS 3 和 4 分别为 1.2ml 和 0.6ml 时出现大幅平台期。对于 PI-RADS 5 病变,SBx csPCa 附加价值始终低于 4%。

结论

PI-RADS 3 和 4 病变中 IL 体积的增加与 SBx csPCa 附加价值的降低相关。对于诊断目的,如果 IL 分别大于 PI-RADS 3 和 4 的 1.2ml 和 0.6ml,则可以省略男性的 SBx。相反,对于 PI-RADS 5,无论 IL 体积如何,SBx csPCa 附加价值都很小。

相似文献

1
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database.根据 mpMRI 上的指数病变特征评估除靶向活检外还需要进行系统活检的必要性。来自大型多机构数据库的结果。
World J Urol. 2022 Nov;40(11):2683-2688. doi: 10.1007/s00345-022-04155-4. Epub 2022 Sep 23.
2
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series.多参数 MRI 可见病灶男性中前列腺靶向活检方案的优化:我们是否应该针对所有可疑区域?两家机构系列研究的结果。
Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1137-1142. doi: 10.1038/s41391-021-00371-y. Epub 2021 May 3.
3
Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.经会阴模板引导式饱和与靶向前列腺活检的男性前列腺癌检出率。
Prostate. 2022 Feb;82(3):388-396. doi: 10.1002/pros.24286. Epub 2021 Dec 16.
4
[Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5].[针对PI-RADS 5级患者采用靶向活检联合6针系统活检诊断前列腺癌的效能]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Oct 18;55(5):812-817. doi: 10.19723/j.issn.1671-167X.2023.05.006.
5
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer.评估多参数磁共振成像阳性在疑似前列腺癌年轻男性中的临床价值。
Eur Urol Oncol. 2021 Aug;4(4):594-600. doi: 10.1016/j.euo.2019.05.006. Epub 2019 Jun 14.
6
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.弹性融合活检的准确性:比较靶向和系统活检对前列腺癌的检出率。
Prostate. 2023 Feb;83(2):162-168. doi: 10.1002/pros.24449. Epub 2022 Oct 19.
7
A clinical available decision support scheme for optimizing prostate biopsy based on mpMRI.基于 mpMRI 的前列腺活检优化的临床可用决策支持方案。
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):727-734. doi: 10.1038/s41391-021-00489-z. Epub 2022 Jan 24.
8
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.MRI 靶向引导下的前列腺活检:明智应用额外系统活检的探索。
Eur Radiol. 2022 Nov;32(11):7544-7554. doi: 10.1007/s00330-022-08822-3. Epub 2022 May 4.
9
Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study.多参数 MRI 和微超声靶向活检在 PI-RADS 5 病变活检初治患者中的诊断准确性:单机构研究。
World J Urol. 2023 Sep;41(9):2335-2342. doi: 10.1007/s00345-023-04480-2. Epub 2023 Jul 7.
10
Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate.基于 PI-RADS v2.1 分类的 MRI-超声融合靶向活检在前列腺移行/周围区的有效性和准确性。
J Magn Reson Imaging. 2023 Sep;58(3):709-717. doi: 10.1002/jmri.28614. Epub 2023 Feb 11.

引用本文的文献

1
Development and validation of a predictive model based on clinical and MpMRI findings to reduce additional systematic prostate biopsy.基于临床和多参数磁共振成像(MpMRI)结果开发和验证预测模型以减少额外的系统性前列腺活检
Insights Imaging. 2024 Jan 7;15(1):3. doi: 10.1186/s13244-023-01544-0.

本文引用的文献

1
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance.应用前列腺癌影像学改变评估标准预测主动监测患者前列腺癌进展的磁共振成像改变
Eur Urol Oncol. 2021 Apr;4(2):227-234. doi: 10.1016/j.euo.2020.09.004. Epub 2020 Oct 21.
2
Systematic Biopsy of the Prostate can Be Omitted in Men with PI-RADS™ 5 and Prostate Specific Antigen Density Greater than 15.前列腺 PI-RADS™ 5 评分和前列腺特异性抗原密度大于 15 的男性可省略系统前列腺活检。
J Urol. 2021 Aug;206(2):289-297. doi: 10.1097/JU.0000000000001766. Epub 2021 Apr 5.
3
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis.
前列腺多参数磁共振成像与前列腺癌初次治疗后肿瘤学结局的关系:系统评价和荟萃分析。
Eur Urol Oncol. 2021 Aug;4(4):519-528. doi: 10.1016/j.euo.2020.11.008. Epub 2020 Dec 28.
4
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.MRI 靶向、系统和联合活检在前列腺癌诊断中的应用。
N Engl J Med. 2020 Mar 5;382(10):917-928. doi: 10.1056/NEJMoa1910038.
5
Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial.三种基于磁共振成像的前列腺癌靶向活检技术在既往阴性前列腺活检男性中的并发症和不良事件:来自 FUTURE 试验的结果,一项多中心随机对照试验。
Eur Urol Oncol. 2019 Nov;2(6):617-624. doi: 10.1016/j.euo.2019.08.007. Epub 2019 Sep 11.
6
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies.除了多参数磁共振成像靶向活检外,别无选择只能进行系统性前列腺活检。
Eur Urol Oncol. 2020 Feb;3(1):112-118. doi: 10.1016/j.euo.2019.03.002. Epub 2019 Mar 27.
7
Multiparametric MRI for prostate cancer diagnosis: current status and future directions.多参数 MRI 用于前列腺癌诊断:现状与未来方向。
Nat Rev Urol. 2020 Jan;17(1):41-61. doi: 10.1038/s41585-019-0212-4. Epub 2019 Jul 17.
8
Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.磁共振成像引导靶向活检与系统活检检测前列腺癌的比较:系统评价和荟萃分析。
Eur Urol. 2019 Sep;76(3):284-303. doi: 10.1016/j.eururo.2019.04.043. Epub 2019 May 24.
9
Patient Experience of Systematic Versus Fusion Prostate Biopsies.患者对系统前列腺活检与融合前列腺活检的体验。
Eur Urol Oncol. 2018 Aug;1(3):202-207. doi: 10.1016/j.euo.2018.02.005. Epub 2018 May 15.
10
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.前列腺影像报告和数据系统(PI-RADS)评分与指数病变和多灶性、临床显著前列腺癌的相关性。
Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.